UM blueprints sprawling new biotech complex

The University of Miami medical school says that a new, 1.4 million square foot laboratory complex will help propel development of a new biotech cluster in the region. The complex will provide lab and office space to companies commercializing the research work being done at the university. And UM is buying 7.2 acres to make it happen.

''This is a really big project for Miami and for the University of Miami,'' said the dean of UM's medical school, Dr. Pascal Goldschmidt. "It's way beyond the University of Miami, to tell you the truth. There's an opportunity to develop an area of the economy we have not been particularly strong at, but could be strong at.''

- read the article from the Miami Herald

Suggested Articles

Reata’s bardoxolone improved kidney function in a phase 3 trial of patients with a rare form of chronic kidney disease.

The suit alleges the FDA imposed the hold “without notice or explanation” and has since “rebuffed” Regenxbio’s repeated requests for an explanation.

Bolt Biotherapeutics presented positive results from animal trials of its lead drug, a tumor-targeting antibody connected to an immune stimulator.